Dr Reddy`s Lab gets USFDA approval for Risperidone tablet
Dr Reddy`s Labs has received final approval from the US Food and Drug Administration (USFDA) to market Risperidone tablet in the strength of 0.5 mg and 2 mg.
Risperidone is used in psychiatric medicine to treat cases of Schizophrenia, a form of insanity. It acts on certain specific receptors on the brain that helps to modify the behavior of persons so afflicted.
The company manufactures active pharmaceutical ingredients (APIs) and finished dosage forms and markets them globally, with a focus on United States, Europe, India and Russia.
March 03, 2009